Visual Acuity Converter — Snellen, LogMAR, ETDRS, Decimal
The visual acuity converter provides instant and accurate conversion between all major visual acuity notations: Snellen (metric and feet), LogMAR (logarithm of the minimum angle of resolution), ETDRS (Early Treatment Diabetic Retinopathy Study letter score), and decimal notation.
About
Visual acuity (VA) is a quantitative measure of the ability to identify optotypes at a given distance, representing the spatial resolution of the visual system. Several notation systems exist, each with specific clinical applications. Snellen notation (e.g., 20/20 or 6/6) is the most widely recognized standard, representing the testing distance (20 feet or 6 meters) over the letter size identified. LogMAR (Logarithm of the Minimum Angle of Resolution) is the scientific standard, where 0.0 corresponds to 20/20 Snellen and lower values indicate better vision. Each 0.1 LogMAR step corresponds to one line on the ETDRS chart. ETDRS (Early Treatment Diabetic Retinopathy Study) scores range from 0 to 100 letters, with 85 letters equivalent to 20/20 and each letter scored as 0.02 LogMAR. Decimal notation (e.g., 1.0 = 20/20) is commonly used in many countries. The conversion between these systems is precise, using established formulas: LogMAR = -log10(decimal), ETDRS = 85 - 25 × LogMAR, Snellen = 20/10^LogMAR. The LogMAR and ETDRS notations are preferred in clinical research due to their logarithmic nature (equal intervals between lines) making them suitable for statistical analysis and change detection. Snellen remains dominant in clinical practice for its familiarity.
Formula
LogMAR = -log10(decimal). ETDRS = 85 - 25 × LogMAR. Snellen feet = 20 / decimal. Snellen meter = 6 / decimal.
Conversion is based on the established mathematical relationship between notation systems. Enter any ONE of the following: Snellen feet (e.g. 20/40), Snellen metric (e.g. 6/12), LogMAR (e.g. 0.3), ETDRS letter score (e.g. 75), or decimal (e.g. 0.5). The converter will compute all other equivalent values. LogMAR 0.0 = Snellen 20/20 = 6/6 = ETDRS 85 = Decimal 1.0. LogMAR 1.0 = Snellen 20/200 = 6/60 = ETDRS 60 = Decimal 0.1. The VA classification follows WHO/ICD criteria: Normal (20/20 or better), Mild impairment (20/30-20/40), Moderate impairment (20/50-20/80), Severe impairment (20/100-20/200), and Blindness (20/400 or worse).
Score Interpretation
Visual acuity notation conversion is essential in clinical practice and research for several reasons: (1) Different settings use different notations — US clinical practice uses Snellen feet notation, most of the world uses Snellen metric (6m) notation, clinical research uses LogMAR or ETDRS, and European countries often use decimal notation. (2) Clinical trials require standardized notation for endpoint analysis — the vast majority of ophthalmic clinical trials use ETDRS letter scores as the primary endpoint for visual acuity, defining clinically meaningful change as ≥5, ≥10, or ≥15 letter gain/loss (equivalent to 1, 2, or 3 LogMAR lines). (3) Regulatory agencies (FDA, EMA) require ETDRS letter score reporting for ocular drug approvals. (4) The WHO classification of visual impairment uses presenting visual acuity in Snellen notation. The ETDRS chart, designed by Ferris et al. (1982), provides the gold standard for research VA measurement with its logarithmic progression (0.1 LogMAR per line), equal number of letters per line (5), and balanced letter difficulty.
Normal (LogMAR ≤0.0) — 0–0
Normal visual acuity of 20/20 (6/6) or better.
Management: No intervention needed for vision. Continue routine eye examinations as per age guidelines.
Mild Impairment (LogMAR 0.01-0.30) — 1–30
Snellen 20/25 to 20/40. Mild visual reduction.
Management: Optimize refractive correction. Evaluate cause of vision loss. Annual follow-up.
Moderate Impairment (LogMAR 0.31-0.60) — 31–60
Snellen 20/50 to 20/80. Moderate visual reduction.
Management: Comprehensive eye examination. Identify cause (cataract, AMD, diabetic retinopathy, glaucoma). Refraction. Consider low vision aids.
Severe Impairment (LogMAR 0.61-1.00) — 61–100
Snellen 20/100 to 20/200. Severe visual reduction.
Management: Urgent ophthalmology evaluation. Treat underlying cause. Low vision rehabilitation. Driving restriction counseling.
Blindness (LogMAR >1.00) — 101–200
Snellen 20/400 or worse. Meets WHO blindness criteria.
Management: Comprehensive medical retina or neuro-ophthalmology evaluation. Blindness registration if eligible. Low vision rehabilitation. Social support services.
Reference Ranges
| Population | Normal Range | Notes |
|---|---|---|
| Adult visual acuity standards | Snellen 20/20 to 20/400 | 20/20 = normal reference standard. 20/40 = driving license minimum (most jurisdictions). 20/200 = legal blindness (US). 20/400 = WHO blindness. |
Dr. Mahmoud El-Sayed
Dr. Mahmoud El-Sayed is a consultant ophthalmologist with over 15 years of experience across all subspecialties of ophthalmology.
View medical review board & editorial policy →Example Calculation
A patient with diabetic retinopathy has LogMAR visual acuity of 0.7 in the right eye. Converter calculates: Snellen feet 20/100, Snellen metric 6/30, ETDRS letter score 67.5, decimal 0.20. Interpretation: Severe visual impairment. Recommendation: Comprehensive medical retina evaluation, tight glycemic control, consider anti-VEGF therapy if macular edema present.
Related Conditions
Common Mistakes
Converting between Snellen and LogMAR using approximate equivalents rather than formulas
Use exact formulas: LogMAR = -log10(decimal). Snellen 20/40 = decimal 0.5 = LogMAR 0.30. Common approximations (20/20 = 0.0, 20/40 = 0.3, 20/80 = 0.6, 20/200 = 1.0) are accurate, but intermediate values require the formula.
Frequently Asked Questions
What is the difference between presenting and best-corrected visual acuity (BCVA)?
Why is LogMAR preferred over Snellen in research?
References
- Ferris FL, Kassoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol. 1982;94(1):91-96. PubMed
- World Health Organization. ICD-11 for Mortality and Morbidity Statistics: Vision Impairment. 2018.